Cross-species validation of cell cycle arrest markers for acute kidney injury in the rat during sepsis

Intensive Care Medicine Experimental

Volumn 4, Issue 1, 2016, Pages

  Peng, Zhi Yong ^a,b   Zhou, Feihu ^c   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute kidney injury; Biomarkers; Cell cycle arrest; Insulin like growth factor binding protein 7 (IGFBP7); Sepsis; Tissue inhibitor of metalloproteinases (TIMP) 2

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CELL CYCLE ARREST; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID RESUSCITATION; HUMAN; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; URINALYSIS;

EID: 84995955061     PISSN: None     EISSN: 2197425X     Source Type: Journal    
DOI: 10.1186/s40635-016-0086-1     Document Type: Article

References (24)

1. KDIGO AKIWG (2012) Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Inter 2(Suppl 2012):1–138, 1–141
2. Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25
3. Bihorac A, Chawla LS, Shaw AD et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–939
4. Yang Q-H, Liu D-W, Long Y et al (2009) Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect 58:459–464
5. Price PM, Safirstein RL, Megyesi J (2009) The cell cycle and acute kidney injury. Kidney Int 76:604–613
6. Boonstra J, Post JA (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337:1–13
7. Seo D-W, Li H, Qu C-K et al (2006) Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem 281:3711–3721
8. Seo D-W, Li H, Guedez L et al (2003) TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114:171–180
9. Kellum JA, Chawla LS (2015) Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol Dial Transplant 31:16–22
10. Kellum JA, Devarajan P (2014) What can we expect from biomarkers for acute kidney injury? Biomark Med 8:1239–1245
11. Zarbock A, Schmidt C, Van Aken H et al (2015) Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 313:2133–2141
12. Uchino S, Kellum JA, Bellomo R et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813–818
13. Hoste EAJ, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423
14. Zhou F, Peng Z-Y, Bishop JV et al (2013) Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis*. Crit Care Med 42:e270–e278
15. Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212
16. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
17. Yang Y-L, Liu DD, Hsieh N-K, Chen HI (2008) Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats. Chin J Physiol 51:186–195
18. Douthwaite JA, Johnson TS, Haylor JL et al (1999) Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins. J Am Soc Nephrol 10:2109–2119
19. Bach LA, Hale LJ (2015) Insulin-like growth factors and kidney disease. Am J Kidney Dis 65:327–336
20. Zarbock A, Kellum JA (2015) Remote ischemic preconditioning and protection of the kidney—a novel therapeutic option. Crit Care Med 44:607–16
21. Basu RK, Standage SW, Cvijanovich NZ et al (2011) Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray. Crit Care 15:R273
22. Peng Z-Y, Wang H-Z, Srisawat N et al (2012) Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis*. Crit Care Med 40:538–543
23. Kellum JA, Sileanu FE, Murugan R et al (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26:2231–2238
24. Kellum JA, Chawla LS, Keener C et al (2016) The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 193:281–287